Contract notice

Information

Published

Date of dispatch of this notice: 16/09/2020

Expire date: 16/10/2020

External Reference: 2020-263577

TED Reference: 2020/S 183-441487

Contract notice

[NoticeContract]

[Directive201424]

[Section1]: [Ca]

I.1)

[NameAddressContact]

Health Service Executive (HSE)
N/A
Head Office
Naas
Millennium Park
IE
[Contactpoint]: Oonagh Walsh
[AddressPhone]: +353 567784539
[AddressEmail]: oonagh.walsh@hse.ie
[Internets]:
[UrlGeneral]: http://www.hse.ie

I.2)

[JointProcurement]

[JointProcurementCentral]
I.3)

[InfoTendering]

[AddressObtainDocs]:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=174146&B=ETENDERS_SIMPLE
[AddressFurtherinfo]
[AsContactsAbove]:  
[AddressSendTendersRequest]
[AddressSendTendersRequest]
[AddressToAbove]
I.4)

[CaType]

[MaintypePublicbody]
I.5)

[Mainactivity]

[MainactivHealth]

[Section2]: [Object]

II.1)

[QuantityScopeContract]

II.1.1)

[TitleContract]

Invitation to Tender for the Provision of Infliximab Pharmaceutical Product for Letterkenny University Hospital
[Fileref]:  HSE 14102
II.1.2)

[CpvMain]

33600000  - 
II.1.3)

[TypeContract]

[Supplies]
II.1.4)

[DescrShort]

Letterkenny University Hospital is a 360 bedded Hospital, providing a wide range of acute hospital services, on an in-patient, day-case and out-patient basis.
The recent annual usage of Infliximab 100mg vials is approximately 2,950 vials.It is intended to award the Contract to the Tenderer who, in the professional judgement of the Evaluation Group, submits the most economically advantageous tender having regard to the Award Criteria and Weightings outlined in the invitation to Tender.
II.1.5)

[ValueMagnitudeEstimatedTotal]

[ValueExclVat]: 1.00  EUR
II.1.6)

[LotsInfo]

[DivisionLots]: [No]
II.2)

[Description]

II.2.2)

[CpvAdditional]

33600000  - 
II.2.3)

[PlacePerformance]

[MainsiteplaceWorksDelivery]:  
Letterkenny
II.2.4)

[DescrProcurement]

Letterkenny University Hospital is a 360 bedded Hospital, providing a wide range of acute hospital services, on an in-patient, day-case and out-patient basis.
The recent annual usage of Infliximab 100mg vials is approximately 2,950 vials.It is intended to award the Contract to the Tenderer who, in the professional judgement of the Evaluation Group, submits the most economically advantageous tender having regard to the Award Criteria and Weightings outlined in the invitation to Tender.
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.6)

[ValueMagnitudeEstimated]

[ValueExclVat]: 1.00  EUR
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 24
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
Option to extend by 2x12 month periods
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]

[Section3]: [InfoLegal]

III.1)

[ConditionsParticip]

III.1.1)

[SituationPersonalIncl]

[InfoEvaluatingRequir]:  As stated in Tender Documentation
III.1.2)

[EconomicFinancialStanding]

[CriteriaSelectionDocs]
III.1.3)

[TechnicalCapacity]

[CriteriaSelectionDocs]
III.2)

[ConditionsContract]

[Section4]: [Procedure]

IV.1)

[Description]

IV.1.1)

[TypeProcedure]

[ProctypeOpen]
IV.1.8)

[GpaInfo]

[GpaCovered] : [Yes]
IV.2)

[InfoAdmin]

IV.2.2)

[LimitReceiptTendersReqPart]

[Date]:  16/10/2020
[Time]:  12:00
IV.2.4)

[LanguagesAllowed]

[Language_EN]
IV.2.6)

[MinTimeMaintain]

[DurationMonths] : 12  ([FromStatedDate])
IV.2.7)

[OpeningConditions]

[Date]:  16/10/2020
[Time]:  12:00
[OpeningPlace]:  
Etenders

[Section6]: [InfoComplement]

VI.1)

[RecurrenceInfo]

[RecurrentProcurement]:  [No]
VI.4)

[AppealsProcedure]

VI.4.1)

[AppealsBody]

High Court
Dublin
1
IE

VI.4.3)

[AppealsLodging]

[AppealsDeadline]: 
As above